Matches in SemOpenAlex for { <https://semopenalex.org/work/W2178722108> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2178722108 endingPage "1940" @default.
- W2178722108 startingPage "1938" @default.
- W2178722108 abstract "![Graphic][1]</img> What should we be telling our patients about saturated fat and cardiovascular risk? There have been highly publicised systematic reviews of observational data suggesting no relationship between saturated fat and all-cause mortality or coronary heart disease (CHD).1 ,2 This is sensational, but is it correct? Randomised controlled trials (RCTs) are better than observational studies at clarifying effectiveness of interventions, and large numbers of people have been involved in randomised trials of saturated fat reduction over periods of at least 24 months. What do trials tell us about the effects of saturated fat reduction on health? And if we cut down on saturated fat, does it matter what we eat in its place? To find out, we carried out a Cochrane systematic review of RCTs.3 We worked with the WHO Nutrition Guidance Expert Advisory Group (WHO NUGAG) to ensure the review accurately assessed effects of reducing saturated fats on all-cause mortality, cardiovascular morbidity and other health outcomes, and to consider the differential effects on health outcomes of replacement of the energy from saturated fat by polyunsaturated fats, monounsaturated fats, carbohydrates or protein. Review methods followed the Cochrane Handbook for Systematic Reviews of Interventions (http://community.cochrane.org/handbook). The inclusion criteria for the Cochrane review are summarised in table 1, along with key review results.3 View this table: Table 1 PICOT summary for included randomised controlled trials (RCTs) assessing the effects of reducing saturated fat on mortality and CVD Meta-analysis of the 15 included RCTs did not suggest that reducing saturated fat altered risks of all-cause mortality, cardiovascular mortality, CHD mortality, CHD events, non-fatal myocardial infarction (MI) or stroke, but there was a 17% reduction in people experiencing cardiovascular disease (CVD) events and a marginal effect (suggesting a 10% reduction) on those experiencing MI (fatal or non-fatal). In this context we defined CVD events as including … [1]: /embed/inline-graphic-1.gif" @default.
- W2178722108 created "2016-06-24" @default.
- W2178722108 creator A5007103570 @default.
- W2178722108 creator A5017216242 @default.
- W2178722108 creator A5034161245 @default.
- W2178722108 date "2015-10-09" @default.
- W2178722108 modified "2023-10-10" @default.
- W2178722108 title "Cochrane corner: what are the effects of reducing saturated fat intake on cardiovascular disease and mortality?" @default.
- W2178722108 cites W2097301645 @default.
- W2178722108 cites W2151604950 @default.
- W2178722108 doi "https://doi.org/10.1136/heartjnl-2015-308521" @default.
- W2178722108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26453280" @default.
- W2178722108 hasPublicationYear "2015" @default.
- W2178722108 type Work @default.
- W2178722108 sameAs 2178722108 @default.
- W2178722108 citedByCount "5" @default.
- W2178722108 countsByYear W21787221082016 @default.
- W2178722108 countsByYear W21787221082017 @default.
- W2178722108 countsByYear W21787221082018 @default.
- W2178722108 countsByYear W21787221082019 @default.
- W2178722108 countsByYear W21787221082020 @default.
- W2178722108 crossrefType "journal-article" @default.
- W2178722108 hasAuthorship W2178722108A5007103570 @default.
- W2178722108 hasAuthorship W2178722108A5017216242 @default.
- W2178722108 hasAuthorship W2178722108A5034161245 @default.
- W2178722108 hasBestOaLocation W21787221082 @default.
- W2178722108 hasConcept C118552586 @default.
- W2178722108 hasConcept C126322002 @default.
- W2178722108 hasConcept C168563851 @default.
- W2178722108 hasConcept C17744445 @default.
- W2178722108 hasConcept C1862650 @default.
- W2178722108 hasConcept C189708586 @default.
- W2178722108 hasConcept C199539241 @default.
- W2178722108 hasConcept C23131810 @default.
- W2178722108 hasConcept C27415008 @default.
- W2178722108 hasConcept C2778163477 @default.
- W2178722108 hasConcept C2778431760 @default.
- W2178722108 hasConcept C2779473830 @default.
- W2178722108 hasConcept C2780516434 @default.
- W2178722108 hasConcept C3020261727 @default.
- W2178722108 hasConcept C71924100 @default.
- W2178722108 hasConcept C95190672 @default.
- W2178722108 hasConceptScore W2178722108C118552586 @default.
- W2178722108 hasConceptScore W2178722108C126322002 @default.
- W2178722108 hasConceptScore W2178722108C168563851 @default.
- W2178722108 hasConceptScore W2178722108C17744445 @default.
- W2178722108 hasConceptScore W2178722108C1862650 @default.
- W2178722108 hasConceptScore W2178722108C189708586 @default.
- W2178722108 hasConceptScore W2178722108C199539241 @default.
- W2178722108 hasConceptScore W2178722108C23131810 @default.
- W2178722108 hasConceptScore W2178722108C27415008 @default.
- W2178722108 hasConceptScore W2178722108C2778163477 @default.
- W2178722108 hasConceptScore W2178722108C2778431760 @default.
- W2178722108 hasConceptScore W2178722108C2779473830 @default.
- W2178722108 hasConceptScore W2178722108C2780516434 @default.
- W2178722108 hasConceptScore W2178722108C3020261727 @default.
- W2178722108 hasConceptScore W2178722108C71924100 @default.
- W2178722108 hasConceptScore W2178722108C95190672 @default.
- W2178722108 hasIssue "24" @default.
- W2178722108 hasLocation W21787221081 @default.
- W2178722108 hasLocation W21787221082 @default.
- W2178722108 hasLocation W21787221083 @default.
- W2178722108 hasOpenAccess W2178722108 @default.
- W2178722108 hasPrimaryLocation W21787221081 @default.
- W2178722108 hasRelatedWork W1882623301 @default.
- W2178722108 hasRelatedWork W2064970022 @default.
- W2178722108 hasRelatedWork W2082858368 @default.
- W2178722108 hasRelatedWork W2096322575 @default.
- W2178722108 hasRelatedWork W2102646656 @default.
- W2178722108 hasRelatedWork W2115302005 @default.
- W2178722108 hasRelatedWork W2409407719 @default.
- W2178722108 hasRelatedWork W3028786438 @default.
- W2178722108 hasRelatedWork W4213393160 @default.
- W2178722108 hasRelatedWork W4214780521 @default.
- W2178722108 hasVolume "101" @default.
- W2178722108 isParatext "false" @default.
- W2178722108 isRetracted "false" @default.
- W2178722108 magId "2178722108" @default.
- W2178722108 workType "article" @default.
!["![Graphic][1]</img> What should we be telling our patients about saturated fat and cardiovascular risk? There have been highly publicised systematic reviews of observational data suggesting no relationship between saturated fat and all-cause mortality or coronary heart disease (CHD).1 ,2 This is sensational, but is it correct? Randomised controlled trials (RCTs) are better than observational studies at clarifying effectiveness of interventions, and large numbers of people have been involved in randomised trials of saturated fat reduction over periods of at least 24 months. What do trials tell us about the effects of saturated fat reduction on health? And if we cut down on saturated fat, does it matter what we eat in its place? To find out, we carried out a Cochrane systematic review of RCTs.3 We worked with the WHO Nutrition Guidance Expert Advisory Group (WHO NUGAG) to ensure the review accurately assessed effects of reducing saturated fats on all-cause mortality, cardiovascular morbidity and other health outcomes, and to consider the differential effects on health outcomes of replacement of the energy from saturated fat by polyunsaturated fats, monounsaturated fats, carbohydrates or protein. Review methods followed the Cochrane Handbook for Systematic Reviews of Interventions (http://community.cochrane.org/handbook). The inclusion criteria for the Cochrane review are summarised in table 1, along with key review results.3 View this table: Table 1 PICOT summary for included randomised controlled trials (RCTs) assessing the effects of reducing saturated fat on mortality and CVD Meta-analysis of the 15 included RCTs did not suggest that reducing saturated fat altered risks of all-cause mortality, cardiovascular mortality, CHD mortality, CHD events, non-fatal myocardial infarction (MI) or stroke, but there was a 17% reduction in people experiencing cardiovascular disease (CVD) events and a marginal effect (suggesting a 10% reduction) on those experiencing MI (fatal or non-fatal). In this context we defined CVD events as including … [1]: /embed/inline-graphic-1.gif"](?object=%22!%5BGraphic%5D%5B1%5D%3C%2Fimg%3E%20What%20should%20we%20be%20telling%20our%20patients%20about%20saturated%20fat%20and%20cardiovascular%20risk%3F%20There%20have%20been%20highly%20publicised%20systematic%20reviews%20of%20observational%20data%20suggesting%20no%20relationship%20between%20saturated%20fat%20and%20all-cause%20mortality%20or%20coronary%20heart%20disease%20(CHD).1%20%2C2%20This%20is%20sensational%2C%20but%20is%20it%20correct%3F%20Randomised%20controlled%20trials%20(RCTs)%20are%20better%20than%20observational%20studies%20at%20clarifying%20effectiveness%20of%20interventions%2C%20and%20large%20numbers%20of%20people%20have%20been%20involved%20in%20randomised%20trials%20of%20saturated%20fat%20reduction%20over%20periods%20of%20at%20least%2024%20months.%20What%20do%20trials%20tell%20us%20about%20the%20effects%20of%20saturated%20fat%20reduction%20on%20health%3F%20And%20if%20we%20cut%20down%20on%20saturated%20fat%2C%20does%20it%20matter%20what%20we%20eat%20in%20its%20place%3F%20To%20find%20out%2C%20we%20carried%20out%20a%20Cochrane%20systematic%20review%20of%20RCTs.3%20We%20worked%20with%20the%20WHO%20Nutrition%20Guidance%20Expert%20Advisory%20Group%20(WHO%20NUGAG)%20to%20ensure%20the%20review%20accurately%20assessed%20effects%20of%20reducing%20saturated%20fats%20on%20all-cause%20mortality%2C%20cardiovascular%20morbidity%20and%20other%20health%20outcomes%2C%20and%20to%20consider%20the%20differential%20effects%20on%20health%20outcomes%20of%20replacement%20of%20the%20energy%20from%20saturated%20fat%20by%20polyunsaturated%20fats%2C%20monounsaturated%20fats%2C%20carbohydrates%20or%20protein.%20Review%20methods%20followed%20the%20Cochrane%20Handbook%20for%20Systematic%20Reviews%20of%20Interventions%20(http%3A%2F%2Fcommunity.cochrane.org%2Fhandbook).%20The%20inclusion%20criteria%20for%20the%20Cochrane%20review%20are%20summarised%20in%20table%201%2C%20along%20with%20key%20review%20results.3%20View%20this%20table%3A%20Table%201%20PICOT%20summary%20for%20included%20randomised%20controlled%20trials%20(RCTs)%20assessing%20the%20effects%20of%20reducing%20saturated%20fat%20on%20mortality%20and%20CVD%20Meta-analysis%20of%20the%2015%20included%20RCTs%20did%20not%20suggest%20that%20reducing%20saturated%20fat%20altered%20risks%20of%20all-cause%20mortality%2C%20cardiovascular%20mortality%2C%20CHD%20mortality%2C%20CHD%20events%2C%20non-fatal%20myocardial%20infarction%20(MI)%20or%20stroke%2C%20but%20there%20was%20a%2017%25%20reduction%20in%20people%20experiencing%20cardiovascular%20disease%20(CVD)%20events%20and%20a%20marginal%20effect%20(suggesting%20a%2010%25%20reduction)%20on%20those%20experiencing%20MI%20(fatal%20or%20non-fatal).%20In%20this%20context%20we%20defined%20CVD%20events%20as%20including%20%E2%80%A6%20%5B1%5D%3A%20%2Fembed%2Finline-graphic-1.gif%22){kind=link}